INDUCIBLE ANTIBIOTIC RESISTANCE
INDUCIBLE ANTIBIOTIC RESISTANCE
批准号:
3127808
负责人:
Bernard Weisblum
金额:
$11.65万
依托单位国家:
美国
项目类别:
财政年份:
1981
资助国家:
美国
项目状态:
已结题
起止时间:
1981-08-01 至 1996-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The long-term general objective of this research program is to study
regulation of genes whose expression is induced or modified by antibiotics.
The emphasis is on a group of genes that confer antibiotic resistance. The
specific aims of this proposal are to study regulation of
erythromycin-inducible resistance to the macrolide, lincosamide, and
streptogramin B (MLS) antibiotics conferred by Staphylococcus aureus
plasmid pEl94. An inducible 23S rRNA methylase confers resistance by
methylating a specific adenine residue in 23S rRNA, and its synthesis is
induced by erythromycin. Factors that enter into the control of MLS
resistance can be classified according to whether they act on: (1) the rate
of synthesis of the message (transcriptional control), (2) the rate of
degradation of the message (mRNA stability), (3) the efficiency of
utilization of the message (translational control), and (4) the number of
plasmid DNA copies that are available from which to transcribe the message
(plasmid copy number control). Two new aspects of the problem that will
serve as the focus of the present work include: (1) a study of the
interaction between the ErmC methylase, a member of the family of enzymes
that confer MLS resistance, with its 23S rRNA substrate; and (2) a study of
the interaction between the pEl94 Cop protein and its putative binding site
in plasmid DNA, a reaction that is proposed to regulate the expression of
erythromycin resistance by controlling plasmid copy number. In the first
case, we shall attempt to distinguish between structural aspects of the
methylase amino acid sequence that are responsible for the ability to
recognize the 23S rRNA substrate and distinguish it from other potential
substrates such as 16S rRNA as well as to identify the parts of the
sequence that are responsible for catalytic (i.e., methylase) activity. In
the second case, we shall study the interaction between a recently
identified Cop protein specified by plasmid pEl94 and its presumed target
plasmid pEl94 DNA - asking specifically, where does Cop protein bind and
how does this binding ultimately contribute to control the concentration of
plasmid DNA?
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Methyltransferase inhibition assay development
-
批准号:7740341
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2009
-
负责人:Bernard Weisblum
-
依托单位:
Global Regulation of Gene expression in Streptococcus pneumoniae
-
批准号:7843519
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2009
-
负责人:Bernard Weisblum
-
依托单位:
Global Regulation of Gene expression in Streptococcus pneumoniae
-
批准号:7572557
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2009
-
负责人:Bernard Weisblum
-
依托单位:
Methyltransferase inhibition assay development
-
批准号:7860390
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2009
-
负责人:Bernard Weisblum
-
依托单位:
ACTIVATION OF VANS IN VITRO
-
批准号:2591924
-
项目类别:
-
资助金额:$7.2万
-
财政年份:1998
-
负责人:Bernard Weisblum
-
依托单位:
ACTIVATION OF VANS IN VITRO
-
批准号:2887699
-
项目类别:
-
资助金额:$7.2万
-
财政年份:1998
-
负责人:Bernard Weisblum
-
依托单位:
ACTIVATION OF VANS IN VITRO
-
批准号:6170839
-
项目类别:
-
资助金额:$7.2万
-
财政年份:1998
-
负责人:Bernard Weisblum
-
依托单位:
INDUCIBLE ERYTHROMYCIN RESISTANCE
-
批准号:3127806
-
项目类别:
-
资助金额:$14.74万
-
财政年份:1981
-
负责人:Bernard Weisblum
-
依托单位:
INDUCIBLE ERYTHROMYCIN RESISTANCE
-
批准号:3127804
-
项目类别:
-
资助金额:$14.52万
-
财政年份:1981
-
负责人:Bernard Weisblum
-
依托单位:
INDUCIBLE ERYTHROMYCIN RESISTANCE
-
批准号:3127807
-
项目类别:
-
资助金额:$16.33万
-
财政年份:1981
-
负责人:Bernard Weisblum
-
依托单位:
INDUCIBLE ANTIBIOTIC RESISTANCE
-
批准号:3127802
-
项目类别:
-
资助金额:$17.94万
-
财政年份:1981
-
负责人:Bernard Weisblum
-
依托单位:
INDUCIBLE ANTIBIOTIC RESISTANCE
-
批准号:2060669
-
项目类别:
-
资助金额:$19.3万
-
财政年份:1981
-
负责人:Bernard Weisblum
-
依托单位:
INDUCIBLE ANTIBIOTIC RESISTANCE
-
批准号:3127809
-
项目类别:
-
资助金额:$18.68万
-
财政年份:1981
-
负责人:Bernard Weisblum
-
依托单位:
INDUCIBLE ANTIBIOTIC RESISTANCE
-
批准号:2060668
-
项目类别:
-
资助金额:$18.58万
-
财政年份:1981
-
负责人:Bernard Weisblum
-
依托单位:
REGULATION OF AN ANTIBIOTIC RESISTANCE DETERMINANT
-
批准号:3127803
-
项目类别:
-
资助金额:$12.72万
-
财政年份:1981
-
负责人:Bernard Weisblum
-
依托单位:
INDUCIBLE ERYTHROMYCIN RESISTANCE
-
批准号:3127805
-
项目类别:
-
资助金额:$14.73万
-
财政年份:1981
-
负责人:Bernard Weisblum
-
依托单位:
INDUCIBLE ERYTHROMYCIN RESISTANCE
-
批准号:3127801
-
项目类别:
-
资助金额:$12.19万
-
财政年份:1981
-
负责人:Bernard Weisblum
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Streptomyces rochei D21E05 次级代谢产物分离纯化及其活性功能研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:关鹏
-
依托单位:
Streptomyces rimosus M527特异性高强度合成龟裂霉素的多模块协同改造
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:马正
-
依托单位:
深海放线菌Streptomyces sp. 11695的抗菌活性次级代谢产物基因组挖掘
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:罗明和
-
依托单位:
基于TAG途径解析 Streptomyces exfoliates A1013Y中蓝色素代谢调控分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:朱运平
-
依托单位:
基因导向的海洋链霉菌Streptomyces sp. LC13中次级代谢产物的挖掘和bacaryolane C的生物合成研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:朱宏杰
-
依托单位:
放线菌Streptomyces mediolani EM-B2的生物脱氮机理研究
-
批准号:42167019
-
项目类别:地区科学基金项目
-
资助金额:36万元
-
批准年份:2021
-
负责人:何腾霞
-
依托单位:
链霉菌新菌株Streptomyces samsunensis F2农用抗生素先导物发掘及生防机制研究
-
批准号:2020JJ4386
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:刘红艳
-
依托单位:
天目山来源链霉菌Streptomyces sp. SY1322中morindolestatin类新颖咔唑生物碱获取及其铁死亡抑制活性研究
-
批准号:LY21H300001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:马列峰
-
依托单位:
Streptomyces sp. Gö66 中基于基因组挖掘的新颖非核糖体肽的发现及生物合成机制的研究
-
批准号:31972852
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2019
-
负责人:蔡晓凤
-
依托单位:
链霉菌Streptomyces sp. G0051B 中膦酸类抗生素Argolaphos A的生物合成研究
-
批准号:31870050
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2018
-
负责人:高江涛
-
依托单位: